We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Can Resistance Enhance Selection of Treatment? (CREST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00262717
Recruitment Status : Completed
First Posted : December 7, 2005
Last Update Posted : June 9, 2006
Boehringer Ingelheim
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.
Roche Pharma AG
Diagnostic Technology
Perkin Elmer Inc.
Information provided by:
Kirby Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Estimated Study Completion Date : August 2002